Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Gross Profit (2020 - 2022)

iBio (IBIO) has disclosed Gross Profit for 3 consecutive years, with $46000.0 as the latest value for Q2 2022.

  • Quarterly Gross Profit fell 84.87% to $46000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Jun 2022, up 57.83% year-over-year, with the annual reading at $2.2 million for FY2022, 138.39% up from the prior year.
  • Gross Profit for Q2 2022 was $46000.0 at iBio, down from $1.9 million in the prior quarter.
  • The five-year high for Gross Profit was $1.9 million in Q1 2022, with the low at $10000.0 in Q1 2020.
  • Average Gross Profit over 3 years is $437100.0, with a median of $287500.0 recorded in 2020.
  • Peak annual rise in Gross Profit hit 2620.0% in 2021, while the deepest fall reached 88.87% in 2021.
  • Over 3 years, Gross Profit stood at $494000.0 in 2020, then tumbled by 88.87% to $55000.0 in 2021, then dropped by 16.36% to $46000.0 in 2022.
  • According to Business Quant data, Gross Profit over the past three periods came in at $46000.0, $1.9 million, and $55000.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.